Regulatory Sourcebook eBook
Read the article:
Considering Titanium Dioxide Regulatory Changes
Read the eBook:
Pharmaceutical Technology’s Regulatory Sourcebook eBook.
CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Considering Titanium Dioxide Regulatory Changes
Published on:
Jennifer Markarian
Pharmaceutical Technology, Pharmaceutical Technology, Regulatory Sourcebook, September 2021, Volume 2021 eBook, Issue 3
EFSA’s evaluation of risk in food products raises implications for drug product formulations.
Titanium dioxide is widely used for adding opacity and brightness in many products. A May 2021 evaluation from the European Food Safety Authority (EFSA), which declared that titanium dioxide is unsafe for food products, alarmed other industries that rely on the ingredient. Although changes are not required in pharmaceutical products, some supplement and drug manufacturers and their suppliers have considered potential alternatives.
Advertisement
Read this article in Pharmaceutical Technology’s Regulatory Sourcebook eBook.
Article Details
Pharmaceutical Technology
eBook: Regulatory Sourcebook
September 2021
Pages: 8-9
Citation
When referring to this article, please cite it as J. Markarian, “Considering Titanium Dioxide Regulatory Changes,” Pharmaceutical Technology Regulatory Sourcebook eBook (September 2021).
